Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
San Rafael, Bulacan, Philippines, April 02, 2026 (GLOBE NEWSWIRE) -- One and One Green Technologies. INC (“One and One” or the “Company”) (NASDAQ: YDDL), a Philippines-based recycler holding a...
-
Pharming Group today announced filing of its 2025 Annual Report and Annual Report on Form 20-F, available at annualreport.pharming.com.
-
Initial deployment of AI-powered edge video solutions based on Maris-Tech’s field-proven Jupiter product line Rehovot, Israel, March 31, 2026 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK,...
-
Pilot program to demonstrate integrated multi-sensor battlefield awareness capabilities for armored platform crews Rehovot, Israel, March 27, 2026 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK,...
-
Cyabra Common Stock Expected to Begin Trading on Nasdaq on March 27, 2026 under the ticker symbol “CYAB” New York, NY, March 27, 2026 (GLOBE NEWSWIRE) -- Cyabra, Inc. (“Cyabra”) (f/k/a Trailblazer...
-
KFAR SABA, Israel, March 27, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for...
-
Continued engagement reflects ongoing operational deployment and customer confidence in Maris-Tech’s technology Rehovot, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK,...
-
DOVER, USA, March 25, 2026 (GLOBE NEWSWIRE) -- E-Power Inc. (“E-Power”, the “Company”, “we” or “our”) (NASDAQ: EPOW), a global leader in energy storage battery anode materials and integrated...
-
Collaboration leverages Converge Bio's proprietary generative AI to design and optimize novel tri-specific antibodies for oncology needs AI-driven development strategy designed to significantly...
-
Plenary Presentation Highlights How Aligning Inflammatory Biomarker Enrichment with Mechanism of Action Offers a Blueprint for Success in Alzheimer’s Drug Development Boca Raton, FL, March 19, 2026 ...